You are here

  • Home
  • Archive
  • Volume 68, Issue 4
  • EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

Article info

Article menu
Download PDFPDF
Recommendations
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

Authors

  1. Professor C Gordon, Rheumatology (East Wing), Division of Immunity and Infection, The Medical School, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK; p.c.gordon{at}bham.ac.uk
View Full Text

Citation

Bertsias GK, Ioannidis JPA, Boletis J, et al
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Annals of the Rheumatic Diseases 2009;68:477-483.

Publication history

  • Accepted April 7, 2008
  • First published April 23, 2008.
Online issue publication 
September 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism